GranuLab (M) Sdn Bhd – a BioNexus Status Company (BNX 100217), was established since May 2006. It is a medical device manufacturing company for synthetic bone graft GranuMas®.
Granulab is a subsidiary of SIRIM Tech Venture (STV), a company wholly owned by SIRIM Berhad. Granulab manufacturing facility is certified with ISO 13485:2016 by BSI Netherlands and, Good Distribution Practice for Medical Device (GDPMD). The facility is well equipped and capable of producing multiple types, form, shape and size of synthetic bone grafts to cater to the needs of clients, hospitals and patients.
The company will continue to foster close collaboration with the Advanced Materials Research Centre (AMREC) of SIRIM for materials development and the technologies of producing Hydroxyapatite into granular bone graft product.